Literature DB >> 17827787

Novel SNPs in cytochrome P450 oxidoreductase.

Steven N Hart1, Ye Li, Kaori Nakamoto, Chris Wesselman, Xiao-bo Zhong.   

Abstract

Cytochrome P450 oxidoreductase (POR) is the single flavoprotein which donates electrons to the microsomal cytochrome P450 enzymes for oxidation of their substrates. In this study, we sequenced all 15 exons and the surrounding intronic sequences of POR in 100 human liver samples to identify novel and confirm known genetic polymorphisms in POR. Thirty-four single nucleotide polymorphisms (SNPs) were identified including 9 in the coding exons (5 synonymous and 4 nonsynonymous), 20 in the intronic regions, and 5 in the 3'-UTR. Of these, 9 were novel SNPs, including three nonsynonymous SNPs, SNH313003 (817733G>C; K49N), SNH313020 (848661C>A; L420M), and SNH313029 (849577T>C; L577P) with minor allele frequencies of 0.005, 0.045, and 0.020, respectively. We also confirmed a previously reported non-synonymous SNP rs1057868 (A503V) as well as five synonymous SNPs (G5G, T29T, P129P, S485S, and S572S) all with allele frequencies similar to those previously reported. Structurally, these polymorphisms occur in different regions: SNH313003 (K49N) in the amino-terminal tail, SNH313020 (L420M) in the connecting domain, SNH313029 (L577P) in the NADPH-binding domain, and rs1057868 (A503V) in the FAD binding domain.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17827787     DOI: 10.2133/dmpk.22.322

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  4 in total

1.  Human cytochrome P450 oxidoreductase deficiency caused by the Y181D mutation: molecular consequences and rescue of defect.

Authors:  Christopher C Marohnic; Satya P Panda; Karen McCammon; José Rueff; Bettie Sue Siler Masters; Michel Kranendonk
Journal:  Drug Metab Dispos       Date:  2009-11-02       Impact factor: 3.922

2.  Mutations of human cytochrome P450 reductase differentially modulate heme oxygenase-1 activity and oligomerization.

Authors:  Christopher C Marohnic; Warren J Huber Iii; J Patrick Connick; James R Reed; Karen McCammon; Satya P Panda; Pavel Martásek; Wayne L Backes; Bettie Sue S Masters
Journal:  Arch Biochem Biophys       Date:  2011-06-28       Impact factor: 4.013

3.  Nomenclature for alleles of the cytochrome P450 oxidoreductase gene.

Authors:  Sarah C Sim; Walter L Miller; Xiao-Bo Zhong; Wiebke Arlt; Tsutomu Ogata; Xinxin Ding; C Roland Wolf; Christa E Flück; Amit V Pandey; Colin J Henderson; Todd D Porter; Ann K Daly; Daniel W Nebert; Magnus Ingelman-Sundberg
Journal:  Pharmacogenet Genomics       Date:  2009-07       Impact factor: 2.089

4.  Influence of various polymorphic variants of cytochrome P450 oxidoreductase (POR) on drug metabolic activity of CYP3A4 and CYP2B6.

Authors:  Xuan Chen; Li Qiang Pan; Hua Naranmandura; Su Zeng; Shu Qing Chen
Journal:  PLoS One       Date:  2012-06-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.